• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心律管理设备长期监测中的心房颤动变异性

Atrial fibrillation variability on long-term monitoring of implantable cardiac rhythm management devices.

作者信息

Kaplan Rachel M, Ziegler Paul D, Koehler Jodi, Glotzer Taya V, Passman Rod S

机构信息

Department of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

Cardiac Rhythm Disease Management, Medtronic, Inc., Minneapolis, Minnesota.

出版信息

Clin Cardiol. 2017 Nov;40(11):1044-1048. doi: 10.1002/clc.22766. Epub 2017 Aug 11.

DOI:10.1002/clc.22766
PMID:28800149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6490419/
Abstract

BACKGROUND

Atrial fibrillation (AF) burden and duration are predictors of thromboembolic events. The random nature of these measures may affect clinical decision making. The objective of this study was to determine temporal changes in AF burden as detected by continuous monitoring.

HYPOTHESIS

AF burden changes over time when detected by continuous monitoring.

METHODS

A post hoc analysis of patients enrolled in the TRENDS (A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics) study with ≥1 stroke risk factor(s) who were implanted with a dual-chamber cardiac rhythm management device (CRMD) and had AF burden data available for ≥2 years was performed. AF burden was defined as no AF, low AF (<5.5 hours on any given day), or high AF burden (≥5.5 hours in a day), and was first assessed over the initial 30 days following enrollment and then reassessed at 6-month intervals for 2 years.

RESULTS

Among 394 patients included, the average age was 70.2 ± 10.9 years, 71% were male, and mean CHA DS VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke or TIA, vascular disease, age 65-74 years, sex category) score was 3.7 ± 1.6. In the 30-day baseline period, 75.1% of patients had no AF, 11.2% had low AF, and 13.7% had high AF. Over the subsequent 2 years, 40.0% of patients initially classified as no AF or low AF experienced periods with high AF, whereas 59.3% of patients initially classified as high AF experienced ≥6 consecutive months with no AF or low AF. Advanced age was the sole predictor of AF progression.

CONCLUSIONS

Significant temporal variability in AF burden exists when measured continuously with an implantable CRMD.

摘要

背景

房颤(AF)负荷和持续时间是血栓栓塞事件的预测指标。这些指标的随机性可能会影响临床决策。本研究的目的是确定通过连续监测检测到的房颤负荷的时间变化。

假设

通过连续监测检测时,房颤负荷随时间变化。

方法

对参加TRENDS(植入式设备诊断检测到的房性心律失常的临床意义前瞻性研究)研究的患者进行事后分析,这些患者有≥1个卒中危险因素,植入了双腔心脏节律管理设备(CRMD),且有≥2年的房颤负荷数据。房颤负荷定义为无房颤、低房颤负荷(任何一天<5.5小时)或高房颤负荷(一天中≥5.5小时),首先在入组后的最初30天内进行评估,然后每6个月重新评估一次,持续2年。

结果

纳入的394例患者中,平均年龄为70.2±10.9岁,71%为男性,平均CHA DS VASc(充血性心力衰竭、高血压、年龄≥75岁、糖尿病、既往卒中或短暂性脑缺血发作、血管疾病、年龄65 - 74岁、性别类别)评分为3.7±1.6。在30天的基线期,75.1%的患者无房颤,11.2%有低房颤负荷,13.7%有高房颤负荷。在随后的2年中,最初分类为无房颤或低房颤负荷的患者中有40.0%经历了高房颤负荷期,而最初分类为高房颤负荷的患者中有59.3%经历了≥6个连续月无房颤或低房颤负荷。高龄是房颤进展的唯一预测因素。

结论

使用植入式CRMD连续测量时,房颤负荷存在显著的时间变异性。

相似文献

1
Atrial fibrillation variability on long-term monitoring of implantable cardiac rhythm management devices.植入式心律管理设备长期监测中的心房颤动变异性
Clin Cardiol. 2017 Nov;40(11):1044-1048. doi: 10.1002/clc.22766. Epub 2017 Aug 11.
2
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.患有心脏植入式电子设备的女性中风/短暂性脑缺血发作风险增加与更高的心房颤动负担无关。
Europace. 2017 Nov 1;19(11):1767-1775. doi: 10.1093/europace/euw333.
3
Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients.我们能依赖机器吗?在心脏再同步治疗接受者中,设备检测到的心房高心率与房性心律失常高度相符。
Europace. 2016 Mar;18(3):436-44. doi: 10.1093/europace/euv095. Epub 2015 May 27.
4
Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.导管消融与最佳药物治疗对持续性心房颤动伴心力衰竭患者的影响:随机 AMICA 试验。
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007731. doi: 10.1161/CIRCEP.119.007731. Epub 2019 Nov 25.
5
Diagnostic capabilities of devices for cardiac resynchronization therapy.心脏再同步治疗设备的诊断能力。
J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):186-9. doi: 10.2459/JCM.0b013e3283303036.
6
Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.经心外膜和心内膜消融治疗心房颤动后,植入式环路记录器监测证实心房颤动复发率低。
J Cardiovasc Electrophysiol. 2012 Oct;23(10):1059-66. doi: 10.1111/j.1540-8167.2012.02355.x. Epub 2012 May 15.
7
Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.植入式心脏复律除颤器治疗中房颤的作用:死亡、恰当及不恰当电击的危险因素
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208. Epub 2013 Jul 25.
8
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.装置检测到的心房颤动抗凝治疗的处方变化与结局的实践差异。
Circulation. 2019 May 28;139(22):2502-2512. doi: 10.1161/CIRCULATIONAHA.118.038988. Epub 2019 Mar 17.
9
Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.心脏植入式电子设备中房颤负担与心力衰竭住院风险的时间关联。
Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012842. doi: 10.1161/CIRCEP.124.012842. Epub 2024 Jun 28.
10
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.心律失常负担与伴有阵发性心房颤动和心脏植入式电子设备患者心血管结局的风险。
Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010304. doi: 10.1161/CIRCEP.121.010304. Epub 2022 Jan 28.

引用本文的文献

1
Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation.非永久性心房颤动患者心房颤动负荷随时间的变化
Cardiol Res Pract. 2020 Apr 17;2020:9583409. doi: 10.1155/2020/9583409. eCollection 2020.

本文引用的文献

1
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.探索心房高率发作患者的口服抗凝治疗:心房高率发作患者非维生素K拮抗剂口服抗凝剂(NOAH-AFNET 6)试验的原理与设计
Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.
2
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.阿哌沙班用于降低器械检测到的亚临床房颤患者血栓栓塞事件(ARTESiA)试验的原理与设计
Am Heart J. 2017 Jul;189:137-145. doi: 10.1016/j.ahj.2017.04.008. Epub 2017 Apr 24.
3
A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial).隐源性卒中后房颤监测策略的比较(来自隐源性卒中和潜在房颤试验)
Am J Cardiol. 2015 Sep 15;116(6):889-93. doi: 10.1016/j.amjcard.2015.06.012. Epub 2015 Jun 24.
4
The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?永久起搏器植入患者心房颤动的自然病史:心房颤动是一种进行性疾病吗?
J Interv Card Electrophysiol. 2015 Oct;44(1):23-30. doi: 10.1007/s10840-015-0029-x. Epub 2015 Jul 3.
5
Cryptogenic stroke and underlying atrial fibrillation.隐匿性脑卒中与潜在的心房颤动。
N Engl J Med. 2014 Jun 26;370(26):2478-86. doi: 10.1056/NEJMoa1313600.
6
Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices.临床房颤分类法不能很好地反映其时间持续性:来自 1195 例连续植入式设备监测患者的见解。
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2840-8. doi: 10.1016/j.jacc.2014.04.019. Epub 2014 May 7.
7
Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden.通过间歇性心律监测得出的房颤负荷估计值并非对真实房颤负荷的可靠估计。
Pacing Clin Electrophysiol. 2014 Sep;37(9):1210-8. doi: 10.1111/pace.12389. Epub 2014 Mar 25.
8
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.在导管消融前后辨别有症状和无症状的心房颤动发作(DISCERN AF):一项前瞻性、多中心研究。
JAMA Intern Med. 2013 Jan 28;173(2):149-56. doi: 10.1001/jamainternmed.2013.1561.
9
A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.对房颤复发检测的节律监测策略的全面评估:来自 647 例连续监测患者的见解及其对治疗干预后监测的影响。
Circulation. 2012 Aug 14;126(7):806-14. doi: 10.1161/CIRCULATIONAHA.112.098079. Epub 2012 Jul 23.
10
Subclinical atrial fibrillation and the risk of stroke.无症状性心房颤动与卒中风险。
N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575.